Durrie D, Stulting RD, Potvin R, et al. More eyes with 20/10 distance visual acuity at 12 months versus 3 months in a topography-guided excimer laser trial: possible contributing factors. J Cataract Refract Surg. 2019;45:595-600.
Feizi S, Einollahi B, Raminkhoo A, et al. Correlation between corneal topographic indices and higher-order aberrations in keratoconus. J Ophthalmic Vis Res. 2013;8:113-118.
Hwang ES, Schallhorn JM, Randleman JB. Utility of regional epithelial thickness measurements in corneal evaluations. Surv Ophthalmol. 2020;65:187-204.
Li Y, Tan O, Brass R, et al. Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. Ophthalmology. 2012;119:2425-2433.
Lobanoff M, Stonecipher K, Tooma T, et al. Clinical outcomes after topography-guided LASIK: comparing results based on a new topography analysis algorithm with those based on manifest refraction. J Cataract Refract Surg. 2020;46:814-819.
Ma J, Pillar A, Krueger R. Quality of life and satisfaction among physicians after wavefront-optimized vs topography-guided laser vision correction. J Cataract Refract Surg. 2020. doi:10.1097/j.jcrs.0000000000000301. [Epub ahead of print]
Motwani M. The use of WaveLight® Contoura to create a uniform cornea: the LYRA Protocol. Part 1: the effect of higher-order corneal aberrations on refractive astigmatism. Clin Ophthalmol. 2017;11:897-905.
Randleman JB, Woodward M, Lynn MJ, Stulting RD. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008;115:37-50.
Reinstein DZ, Archer TJ, Gobbe M. Corneal epithelial thickness profile in the diagnosis of keratoconus. J Refract Surg. 2009;25:604-610.
Rocha KM, Perez-Straziota CE, Stulting RD, et al. SD-OCT analysis of regional epithelial thickness profiles in keratoconus, postoperative corneal ectasia, and normal eyes. J Refract Surg. 2013;29:173-179.
Stonecipher K, Parrish J, Stonecipher M. Comparing wavefront-optimized, wavefront-guided and topography-guided laser vision correction: clinical outcomes using an objective decision tree. Curr Opin Ophthalmol. 2018;29:277-285.
Stonecipher MK, Stonecipher KG. Influences on enhancement rates in laser vision correction. US Ophthalmic Review. 2016;9:107-109.
Stulting RD, Durrie DS, Potvin RJ, et al. Topography-guided refractive astigmatism outcomes: predictions comparing three different programming methods. Clin Ophthalmol. 2020;14:1091-1100.
Stulting RD, Fant BS, T-CAT Study Group, et al. Results of topography-guided laser in situ keratomileusis custom ablation treatment with a refractive excimer laser. J Cataract Refract Surg. 2016;42:11-18.
Vogt A. Atlas of the Slitlamp Microscopy of the Living Eye. Berlin, Germany: Springer Verlag Berlin-Heidelberg, 1921.

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Faculty

Karl Stonecipher, MD

Clinical Associate Professor of Ophthalmology
University of North Carolina School of Medicine
Medical Director
TLC Laser Eye Centers
Greensboro, North Carolina

Disclosures

Disclosure: Karl Stonecipher, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Eyevance; Eyepoint; Johnson and Johnson; Kala; Lombart; Marco; Nidek; Novartis; Pogotec; Presbia; Refocus; TLC
Served as a speaker or a member of a speakers bureau for: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Eyevance; Eyepoint; Johnson and Johnson; Kala; Lombart; Marco; Nidek; Novartis; Pogotec; Presbia; Refocus; TLC
Received grants for clinical research from: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Presbia; Refocus
Owns stock, stock options, or bonds from: Alphaeon; Strathspey Crown

Ronald Krueger, MD, MSE

McGaw Professor and Chair of Ophthalmology
University of Nebraska Medical Center
Director
Truhlsen Eye Institute
Omaha, Nebraska

Disclosures

Disclosure: Ronald Krueger, MD, MSE, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alcon Labs; Johnson and Johnson Vision
Received grants for clinical research from: Alcon Labs; Bausch; Lomb
Owns stock, stock options, or bonds from: Ocutrx; Rx Sight; Strathespey Crown

James B. Randleman, MD

Professor of Ophthalmology
Cleveland Clinic Cole Eye Institute
Cleveland, Ohio

Disclosures

Disclosure: James B. Randleman, MD, has disclosed no relevant financial relationships.

Editors

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

Yoji Yamaguchi, MA

Associate Scientific Content Manager, Medscape, LLC

Disclosures

Disclosure: Yoji Yamaguchi, MA, has disclosed no relevant financial relationships.

CME Reviewers

Esther Nyarko, PharmD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewedand the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Glaukos Corp
Owns stock, stock options, or bonds from: Glaukos Corp

CME / ABIM MOC

Tricky Refractive Myopia Surgery Cases: How Advanced Topography Can Help

Authors: Karl Stonecipher, MD; Ronald Krueger, MD, MSE; James B. Randleman, MD
CME / ABIM MOC Released: 8/19/2020
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 8/19/2021

Start Activity

Target Audience and Goal Statement

This activity is intended for ophthalmologists and primary care physicians.

The goal of this activity is to improve visual outcomes for patients with myopia seeking refractive correction through corneal surgery, and keep physicians abreast of the latest developments in corneal topography.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Detection of corneal pathologies using topography
- Differences in new topography technologies
- Clinical trial data for wavefront/topography-guided LASIK surgery

Disclosures

Faculty

Karl Stonecipher, MD

Clinical Associate Professor of Ophthalmology
University of North Carolina School of Medicine
Medical Director
TLC Laser Eye Centers
Greensboro, North Carolina

Disclosures

Disclosure: Karl Stonecipher, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Eyevance; Eyepoint; Johnson and Johnson; Kala; Lombart; Marco; Nidek; Novartis; Pogotec; Presbia; Refocus; TLC
Served as a speaker or a member of a speakers bureau for: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Eyevance; Eyepoint; Johnson and Johnson; Kala; Lombart; Marco; Nidek; Novartis; Pogotec; Presbia; Refocus; TLC
Received grants for clinical research from: AcuFocus; Alcon; Allergan; Bausch Health; Espansione; Presbia; Refocus
Owns stock, stock options, or bonds from: Alphaeon; Strathspey Crown

Ronald Krueger, MD, MSE

McGaw Professor and Chair of Ophthalmology
University of Nebraska Medical Center
Director
Truhlsen Eye Institute
Omaha, Nebraska

Disclosures

Disclosure: Ronald Krueger, MD, MSE, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alcon Labs; Johnson and Johnson Vision
Received grants for clinical research from: Alcon Labs; Bausch; Lomb
Owns stock, stock options, or bonds from: Ocutrx; Rx Sight; Strathespey Crown

James B. Randleman, MD

Professor of Ophthalmology
Cleveland Clinic Cole Eye Institute
Cleveland, Ohio

Disclosures

Disclosure: James B. Randleman, MD, has disclosed no relevant financial relationships.

Editors

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

Yoji Yamaguchi, MA

Associate Scientific Content Manager, Medscape, LLC

Disclosures

Disclosure: Yoji Yamaguchi, MA, has disclosed no relevant financial relationships.

CME Reviewers

Esther Nyarko, PharmD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Ophthalmology

CME / ABIM MOC

Tricky Refractive Myopia Surgery Cases: How Advanced Topography Can Help

Authors: Karl Stonecipher, MD; Ronald Krueger, MD, MSE; James B. Randleman, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 8/19/2020

Valid for credit through: 8/19/2021

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Topography: What’s New for Refractive Myopia Surgery?

Dr Stonecipher reviews the latest developments in topography-guided refractive myopia surgery.
Karl Stonecipher, MD

Challenges in Detection of Corneal Pathologies and Risk Factors for Poor Outcomes

Dr Randleman discusses the assessment of pathologies and risk factors in patients presenting for refractive surgery evaluation.
James B. Randleman, MD

Challenges in Pre-Existing Higher Order Aberrations and Astigmatism

Dr Krueger uses case studies to examine some of the challenges of topography-guided LASIK surgery.
Ronald Krueger, MD

Page 1 of 4

Topography: What's New for Refractive Myopia Surgery?

CME / ABIM MOC Information Download Slides

Activity Transcript

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

References

Faculty and Disclosures

Faculty

Karl Stonecipher, MD

Ronald Krueger, MD, MSE

James B. Randleman, MD

Editors

Pakinam Aboulsaoud, PharmD

Yoji Yamaguchi, MA

CME Reviewers

Esther Nyarko, PharmD

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME / ABIM MOC

Tricky Refractive Myopia Surgery Cases: How Advanced Topography Can Help

Target Audience and Goal Statement

Disclosures

Faculty

Karl Stonecipher, MD

Ronald Krueger, MD, MSE

James B. Randleman, MD

Editors

Pakinam Aboulsaoud, PharmD

Yoji Yamaguchi, MA

CME Reviewers

Esther Nyarko, PharmD

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Tricky Refractive Myopia Surgery Cases: How Advanced Topography Can Help

Contents of This CME Activity

Topography: What’s New for Refractive Myopia Surgery?

Challenges in Detection of Corneal Pathologies and Risk Factors for Poor Outcomes

Challenges in Pre-Existing Higher Order Aberrations and Astigmatism